Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Titration Study to Evaluate the Efficacy and Safety Safety of AZOR in Multiple Subgroups of Hypertensive Subjects Who Are Non-Responders to Anti-Hypertensive Monotherapy

NCT00791258 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00791258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00791258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Titration Study to Evaluate the Efficacy and Safety Safety of AZOR in Multiple Subgroups of Hypertensive Subjects Who Are Non-Responders to Anti-Hypertensive Monotherapy
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2008
Completion date
September 30, 2009
Enrollment
999 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension